Skip to content

Net margin at other companies

Pfizer logo
PfizerPFE
15.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
21.8%-2.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-606.2%-212pp
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
53.9%+16.7pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-154.9%-182pp

Other financials

Income statement

See full
Revenue$34.4M+55.5%
Operating income-$84.2M-13.1%
Net income-$69.2M-5.6%
EPS (diluted)-$0.71+13.4%

Balance sheet

See full
Cash & equivalents$144.1M+60.2%
Total debt$82.2M-6.5%
Total equity$1.5B+95.8%
Total assets$1.7B+81.7%

Cash flow

See full
Operating cash flow-$88.8M-12.2%
CapEx$434.0K-7.1%
Free cash flow-$89.3M-12.1%

Valuation

See full
Market cap$7.44B+283%
Enterprise value$7.38B+280%
P/S144.5×+111×

Profitability

See full
Operating margin-697.7%+635pp
FCF margin-474%+92.4pp

Returns & leverage

See full
Return on equity-27.1%-3.7pp
Debt / equity0.1×-0.1×
Current ratio10.8×+2.3×

Where this comes from

Calculated from Kymera Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kymera Therapeutics's net margin?
Kymera Therapeutics (KYMR) reported net margin of -612% in Q1 2026.
How has Kymera Therapeutics's net margin changed year-over-year?
Kymera Therapeutics's net margin decreased by 49.6% year-over-year, from -409.1% to -612%.
What is the long-term trend for Kymera Therapeutics's net margin?
Over 5 years (2020 to 2025), Kymera Therapeutics's net margin has grown at a 42.7% compound annual growth rate (CAGR), from -134% to -794.1%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.